CSL has the second largest flu vaccine business in the world. This will become a much more significant contributor to their revenue and earnings over the next 3-5 years as per their presentation. With an ageing population that is living longer, annual flu vaccine use is going to keep climbing, notwithstanding the occasional pandemic that will further increase use.
Goodbye to $100?, page-16
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$311.70 |
Change
0.580(0.19%) |
Mkt cap ! $150.6B | |||
| Open | High | Low | Value | Volume |
| $308.37 | $311.70 | $307.33 | $411.6M | 1.374M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 55 | $310.93 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $311.74 | 904 | 1 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| CSL (ASX) Chart |